Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Eden LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 11.50p 11.00p 12.00p 11.50p 11.50p 11.50p 103,585 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.9 -0.8 -0.3 - 23.83

Eden Share Discussion Threads

Showing 6126 to 6145 of 6150 messages
Chat Pages: 246  245  244  243  242  241  240  239  238  237  236  235  Older
DateSubjectAuthorDiscuss
18/1/2019
18:12
Jak, I'm well aware of cash situation. You seem to be unaware of the fundamental investment case, let alone proximity to break even, so I'm surprised you're here. I've invited you several times to show me your full appraisal of the opportunity, and you refuse to do this. So you're either in ignorance of it, or in denial. That is not a conversation. Unless I hear further from you in relation to the above, I will assume you are here to make mischief and place you on filter. Best, B5
brucie5
18/1/2019
17:30
Investing, I'm not opposed to Sipcam/Sumitomo taking a bigger stake. I'd need to see the terms and reasoning before making a judgement as to it's value. I base my guess, as that is all it is, on actions in the past. I'm no doubt wildly off target, but saying that Eden has a good record of working out strategic investments like LivingBridge and Sipcam.
supersonico
18/1/2019
17:29
Brucie5, Instead of building a calendar how about building a financial model? I have. And it forecasts yet another year of losses. Given EDEN's margins I estimate that it needs to quadruple turnover in order to just breakeven (never mind actually make a profit). Hence why I am supremely confident that they will need to place yet again. Do the numbers and you will quickly see that I am right. JakNife
jaknife
18/1/2019
17:10
Well personally I'd prefer stake building to begin at 50p, but... So in a sense I at least share your sentiment...
brucie5
18/1/2019
16:31
FWIW, I don't agree it would a disaster for SIPCAM to up their stake at current levels, let alone 30p; it would be thoroughly realistic. Depends how much they take of course. By looks of, 2019 may be no more than modest b/e.
brucie5
18/1/2019
15:54
Investing, Why a Disaster? It's my prediction for 2019 along with No Bayer CAP and Antoine Biron selling TT from the back of a Citroen HY Van in West Ealing.
supersonico
18/1/2019
15:54
I'm trying to build a notional calendar for 2019 with key events expected. As many here, I expect this year to be key to moving the company forward, in terms of regulatory permissions (Cedroz USA), product launches (Bayer/TT), and news of Sustaine. So I'd like to invite posters to assist in building the calendar, which might be helpful to us in teasing out some of those pieces of expected news that Investing put together last year. I'll start the bidding with where we are now. Feel free to add suggestions and I'll keep an updated calendar with your attributed ideas. Jan. Trading update. 1m loss; revenue 2.8m up 48%; sales 1.6m up 100%; TT and Bayer delayed. Feb. News on TT headlice? Proactive presentation March Results published with guidance from Shore for 2019. April Bayer? May June July Aug Sept Oct Nov Dec
brucie5
18/1/2019
14:06
We (Eden) won't be around by the time Africa gets on board.
investingisatrickygame
18/1/2019
14:01
Investing post 5562. edenvulnerabletoanoffer It's much easier to see reasons why what you suggest will happen than why it won't. It also lends itself to questions of current stakes and those stakes increasing given the market opportunity in the Medium term.
supersonico
18/1/2019
11:49
Super We have way more than that to our advantage. We have IP, time and money hxxps://www.syngenta.com/how-we-do-it/research-and-development/how-we-make-new-products Who in agriculture, given the bio trend and barriers to entry can ignore this and Eden as soon as Sipcam/Eden announces co-encapsulation success! Eden are a steel at today's price +x. R & D time from scratch in a fast moving market and no first mover advantage will be/is a costly and potentially dangerous strategic decision if you don't have one foot in the door. # edenvulnerabletoanoffer :)
investingisatrickygame
18/1/2019
11:15
I agree and think that's part of the picture but I do also think that sentiment will step change dramatically on either Catalyst news on any front be it co- encapsulation or Sustaine or other but also as the wider Sumitomo and Eastman distribution picture becomes more evident. We have the dual picture of a rapidly growing global market in biopesticides on one hand and Eden's evolving growth within that sphere on at least two fronts so far disclosed which given the maturity of the Crop protection vertical and the Sumitomo relationship could expand quiet rapidly imo.
supersonico
18/1/2019
10:48
Nice little ramp on Mike Walters website this morning. Gone are the days that would positively impact Eden's share price It's simply a case of "show us the profits" before this share price is gonna rise significantly.
quazie12
17/1/2019
13:15
Expert to farmers: Pesticide misuse may cause export trouble hTTps://www.ckom.com/2019/01/14/expert-to-farmers-pesticide-misuse-may-cause-export-trouble/#.XEB5TRo0_vU.twitter Global markets are becoming more sensitive to the presence of pesticides in crop imports, and farmers in Saskatchewan and across Canada need to pay attention to those concerns. That was the message from Cam Dahl, president of Cereals Canada, to a crowd at the annual Crop Production Show on Monday in Saskatoon. Dahl emphasized the need for farmers to use pesticides responsibly, and follow the label directions to the letter, to avoid causing an international market disruption. “We have countries, and activists, that are looking for reasons to put up trade barriers,” he said after his presentation. “My message to farmers is we need to look at ways of ensuring that we’re not giving them the hooks to hang a trade barrier on.” He noted the rationale has already been used by Italy to erect barriers on Canadian durum wheat, which cut imports from over one million tonnes to below 400 thousand tonnes after concerns were raised over the health and safety of Canadian crops. He also pointed to the rise of protectionist populism in other European markets, and the recent trade spat between Canada and the U.S. during NAFTA negotiations. Dahl said some markets are instituting a zero-tolerance policy for the presence of certain pesticide residues, which can make the margin of error for Canadian farmers very thin since some products are measured in parts-per-billion He noted there is frustration among crop producers because Canadian farmers are typically well below the scientifically-established safe maximums for pesticides like glyphosates. But the criticism isn’t based in science, he said. “It’s impossible to meet all these demands when we move away from science,” Dahl said. “The best thing farmers can do is ensure they’re following the labelling. The right rate at the right time, following the pre-harvest interval for products that are applied in fall, ensuring glyphosate isn’t applied to green crops.” He added that farmers must not underestimate the impact of their crops on the market, no matter how small they may be. “What they do on their farm matters, and it matters to export markets,” Dahl said. “There needs to be a bigger awareness in the agriculture community that we’re not just small little bit-players … Those farm practices matter, and not just on the macro level.” ………………………………….. MEPs vote to increase transparency in pesticide approval hTTps://www.agriland.ie/farming-news/meps-vote-to-increase-transparency-in-pesticide-approval/
supersonico
17/1/2019
12:10
Morning Northwick, Re SEE..Is a Buy imo Huge Auto and Aviation potential maturing 2020/1. share price is pants but potential is great just like here:) I'm expecting news to push this back up shortly. Hopefully Toyota. Lewbo18 on SEE Lse has a good handle on potential. Re Mevalone. Again same picture imo. Good foundations being laid short term targets don't really give a picture of global roll out potential numbers with Sumitomo/ Eastman. Stake building time now imo. TTand Bayer need further clarification. Atm it looks like the geniuses struggle to tie their own shoe laces but I expect that to change. What's curious is the Silence of the Redwings..they must be getting their berries some place else.
supersonico
17/1/2019
11:42
SuperExcuse my typos . Need to go to Spec savers
northwick
17/1/2019
11:41
Gm Super Your current view on 'See', if any?Re Mevalone Sales- Did Eden reach its own target for 2018 Sales? I fear not when compared to what Shore had pencilled in, which wouldn't included any singing on fee or option fees because they weren't guaranteed or secured? Your view, please
northwick
17/1/2019
10:57
Inside 6 Priory Court right now. hTTps://twitter.com/tagesschau/status/1085610253922828289
supersonico
17/1/2019
05:58
Investing...You have latched onto a particular comment I made, but to be clear, that comment is only relevant if nothing is forthcoming in terms of a change/update! I remain of the opinion that something has changed with regard to Terpenetech, but I am hopeful that any change will ultimately be for the better (even if that means a relatively short delay). One change I did note was that the commentary stated TerpeneTech as actively working to establish distribution partners in the United States, but previously commentary stated that distribution partners were being established/finalised in countries only within the European Economic Area. Eden has already been granted regulatory clearance across the European Economic Area. Obviously regulatory clearance will also be needed in the US, but I note that TerpeneTech has apparently been preparing its regulatory submission for the US for quite some time. So is it possible that a larger distribution deal or partner has entered into the scheme of things? Time will tell! I had missed the following coverage, where Shore Capital analysts are quoted as saying that they will update their full-year 2019 financial forecasts for Eden Research after the preliminary results due in March - Shore Capital sees number of “potentially exciting” product applications for Eden Research pending authorisations 15:35 15 Jan 2019 “Whilst authorisations need to come through, the length and breadth of activity is genuinely encouraging to our minds and we expect momentum to further build in FY2019" Eden Research PLC (LON:EDEN) is advancing a number of product applications, which Shore Capital’s analysts think remain “potentially exciting opportunities”, albeit they will only model their financial impact once authorisations come through. In a note to clients following a year-end trading update from the biopesticides products developer, the ‘house’ broker’s analysts said: “Overall, we see FY2018 as a year of good progress for Eden as it demonstrably builds a product portfolio capable of driving attractive medium-to-long term prospects.” They added: “Whilst authorisations need to come through, the length and breadth of activity is genuinely encouraging to our minds and we expect momentum to further build in FY2019, especially if permission come through in the USA, the largest market for crop protection products in the World.“ Full story - https://tinyurl.com/Eden-Genuinely-Encouraging
wan
16/1/2019
21:54
Agree with the future revenue build. The trick nevertheless always being, to get it over the line to profits.
brucie5
16/1/2019
21:54
There may need to be some chunky milestones/licensing fees this year, to forestall jak's cash all. I certainly expect there to be. What sorts of deal on Sustaine are you expecting, beyond a further equity stake?
brucie5
Chat Pages: 246  245  244  243  242  241  240  239  238  237  236  235  Older
Your Recent History
LSE
EDEN
Eden
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190118 19:36:12